- Processing Solutions
- Agitators
- Asset Management
- Automation
- Blowers & Fans
- Centrifuges
- Chillers
- Compressors
- Conveyors
- Dryers & Evaporators
- Feeders
- Filtration & Separation
- Flowmeters
- Fluid Flow
- Heat Exchangers
- Instrumentation
- Level Measurement
- Maintenance & Safety
- Mixing & Blending
- Motors & Drives
- Oil Skimmers
- Piping & Tubing
- Packaging Equipment
- Powder & Bulk Solids
- Process Control
- Pumps & Seals
- Size Reduction
- Tanks & Vessels
- Valves & Actuators
- Weighing
- More
- Newsletters
- White Papers
- Buyer's Guide
- Videos
- Events
- Advertise
More
BRENTFORD, UK — The UK’s biggest drugmaker GlaxoSmithKline Plc has agreed to settle 20,000 more lawsuits alleging its diabetes medication Avandia caused heart attacks, Bloomberg reported.
The company has already agreed to pay $3 billion to resolve government claims that it illegally marketed Avandia and other drugs.
“We are pleased the mediation has successfully resulted in the settlement of a significant number of the remaining cases,” Kiesel, one of the lead lawyers for plaintiffs in the Avandia litigation, said.
